A cost‐effectiveness analysis of hormone replacement therapy in the menopause∗

1 March 1992

journal article
research article
Published by AMPCo in The Medical Journal of Australia

Vol. 156 (5) , 312-316
https://doi.org/10.5694/j.1326-5377.1992.tb139784.x

Abstract

Objective: To evaluate the cost‐effectiveness of hormone replacement therapy in the menopause with particular reference to osteoporotic fracture and myocardial infarction. Design: The multiple‐decrem...

This publication has 28 references indexed in Scilit:

UNCOUPLING OF BONE FORMATION AND RESORPTION BY COMBINED OESTROGEN AND PROGESTAGEN THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS
The Lancet, 1985
Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment
Maturitas, 1984
The determination of the incidence of acute myocardial infarction from hospital morbidity records
Journal of Chronic Diseases, 1984
A convenient approximation of life expectancy (the “DEALE”): II. Use in medical decision-making
The American Journal of Medicine, 1982
Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy
New England Journal of Medicine, 1981
Predominance of Early Endometrial Cancers After Long-term Estrogen Use
JAMA, 1980
Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
New England Journal of Medicine, 1980
Effects of long-term estrogen replacement therapy
American Journal of Obstetrics and Gynecology, 1979
BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENT
The Lancet, 1978
Foundations of Cost-Effectiveness Analysis for Health and Medical Practices
New England Journal of Medicine, 1977